Cardinal Health News

DUBLIN, Ohio, June 1, 2012 /PRNewswire/ -- Cardinal Health today announced that it will manufacture and distribute Amyvid, Eli Lilly and Company's new diagnostic imaging agent that aids in the evaluation of adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline.

Overview -- Standard & Poor's Ratings Services has revised its criteria regarding the linkage of issuers' long-term and short-term ratings as they relate to liquidity.

Cardinal Health, Inc. , Detroit Medical Center , Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal /PRNewswire/ -- Cardinal Health, Detroit Medical Center and Henry Ford Health System today announced a unique collaborative effort to spur urban renewal and bring jobs to the city of As part of the economic recovery ... (more)

Dublin-based Cardinal Health has filed an application with the Detroit Brownfield Redevelopment Authority to build the 273,520-square-foot facility, with construction starting by the end of the year, the newspaper reports.

One of Cardinal Health Specialty Solutions' flagship service offerings for payors is the development of evidence-based treatment regimens, or clinical pathways, for delivering the best possible care to patients with chronic diseases.

Cardinal Health, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information.

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.

Pharmaceutical wholesaler Cardinal Health Inc. said Tuesday one of its Florida facilities will be barred from shipping controlled substances for two years under a settlement with federal authorities over alleged ineffective controls.

" Cardinal Health , one of the big three pharmaceutical wholesalers, reached an agreement with the U.S. Drug Enforcement Administration, under which Cardinal Health will not ship controlled substances from its Lakeland, Fla., distribution center for two years.

One of the batches consists of notes bearing a 1.9% coupon and maturing on 15 June 2017, whereas the other one is comprised of notes carrying a coupon of 3.2% and falling due on 15 June 2022.

The following were the top stories in The Wall Street Journal on Wednesday. Reuters has not verified these stories and does not vouch for their accuracy.

May 16 - -Standard & Poor's Ratings Services said today that it assigned its 'A-' issue-level rating to Dublin, Ohio-based distributor Cardinal Health Inc.'s proposed senior unsecured notes to be issued in two tranches of $250 million each, maturing in 2017 and 2022.

Pharmaceutical wholesaler Cardinal Health Inc. says one of its Florida facilities will suspend shipments of controlled substances for two years under a settlement with federal authorities over alleged ineffective controls.

Did you know that on average, a surgical sponge is retained in one out of every 8000 surgeries here in the U.S? That amounts to 4000 incidents per year, or 11 per day.

The Drug Enforcement Administration sought to revoke Cardinal's license in February, accusing the company of selling excessive amounts - more than 12 million oxycodone pain pills - to four Florida pharmacies over three years.

By The Associated Press Developments in a phone-hacking scandal involving British newspapers owned by Rupert Murdoch's News Corp.: By The Associated Press Developments in a phone-hacking scandal involving British newspapers owned by Rupert Murdoch's News Corp.: Saks reported a 13 percent bump in first-quarter profit, but weak demand of women's ... (more)

Cardinal Health Inc. said Tuesday it has settled charges by the Drug Enforcement Administration that the company improperly controlled the distribution of pain pills at a Florida facility.

Cardinal Health Inc. said Tuesday it has settled charges by the Drug Enforcement Administration that the company improperly controlled the distribution of pain pills at a Florida facility.

Pharmaceutical wholesaler Cardinal Health Inc. says one of its Florida facilities will suspend shipments of controlled substances for two years under a settlement with federal authorities over alleged ineffective controls.

The Dublin-based company bought Dik Drug Co. for an undisclosed price, MedCity reports.